Assessing Key Stakeholders' Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans.

Published

Journal Article

Cancer survivorship care plans (SCPs) are endorsed to support quality care for cancer survivors, but uptake is slow. We assessed knowledge, needs, and preferences for SCP content and delivery from a wide variety of stakeholders. We focused SCP content for head and neck cancer as it is a disease prone to long-term side effects requiring management from multiple providers. We conducted telephone-based, qualitative interviews. We purposively sampled head and neck cancer survivors (n = 4), primary care physicians in the community (n = 5), and providers affiliated with a large academic medical center (n = 5) who treat head and neck cancer, cancer specialists (n = 6), and nurse practitioners/supportive care staff (n = 5). Interviews were recorded, transcribed, and analyzed using direct content analysis. Few participants reported personal experience with SCPs, but most supported the concept. Several key themes emerged: (1) perceived ambiguity regarding roles and responsibilities for SCPs, (2) a need to tailor the content and language based on the intended recipient, (3) documentation process should be as automated and streamlined as possible, (4) concerns about using the SCP to coordinate with outside providers, and (5) that SCPs would have added value as a "living document." We also report SCP-related issues that are unique to serving patients diagnosed with head and neck cancer. Effort is needed to tailor SCPs for different recipients and optimize their potential for successful implementation, impact on care outcomes, and sustainability. Many cancer survivors may not receive a SCP as part of routine care. Survivors could engage their health care team by requesting a SCP.

Full Text

Duke Authors

Cited Authors

  • Zullig, LL; Ramos, K; Berkowitz, C; Miller, JJ; Dolor, RJ; Koontz, BF; Yousuf Zafar, S; Hutch Allen, D; Tenhover, JA; Bosworth, HB

Published Date

  • June 2019

Published In

Volume / Issue

  • 34 / 3

Start / End Page

  • 584 - 591

PubMed ID

  • 29526021

Pubmed Central ID

  • 29526021

Electronic International Standard Serial Number (EISSN)

  • 1543-0154

Digital Object Identifier (DOI)

  • 10.1007/s13187-018-1345-5

Language

  • eng

Conference Location

  • England